Compare Wockhardt with Procter & Gamble Health - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs PROCTER & GAMBLE HEALTH - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

PROCTER & GAMBLE HEALTH 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT PROCTER & GAMBLE HEALTH WOCKHARDT/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x -26.9 43.7 - View Chart
P/BV x 1.2 4.5 26.3% View Chart
Dividend Yield % 0.0 10.5 0.0%  

Financials

 WOCKHARDT   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
PROCTER & GAMBLE HEALTH
Dec-18
WOCKHARDT/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs1,0123,549 28.5%   
Low Rs5321,301 40.8%   
Sales per share (Unadj.) Rs355.9511.4 69.6%  
Earnings per share (Unadj.) Rs-60.361.3 -98.3%  
Cash flow per share (Unadj.) Rs-46.874.0 -63.2%  
Dividends per share (Unadj.) Rs0.01440.00 0.0%  
Dividend yield (eoy) %018.1 0.0%  
Book value per share (Unadj.) Rs257.8927.8 27.8%  
Shares outstanding (eoy) m110.6316.60 666.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.24.7 45.7%   
Avg P/E ratio x-12.839.6 -32.4%  
P/CF ratio (eoy) x-16.532.8 -50.4%  
Price / Book Value ratio x3.02.6 114.5%  
Dividend payout %0717.9 -0.0%   
Avg Mkt Cap Rs m85,37940,257 212.1%   
No. of employees `0006.31.1 551.5%   
Total wages/salary Rs m9,3711,313 713.8%   
Avg. sales/employee Rs Th6,295.07,486.7 84.1%   
Avg. wages/employee Rs Th1,498.31,157.6 129.4%   
Avg. net profit/employee Rs Th-1,066.3897.2 -118.8%   
INCOME DATA
Net Sales Rs m39,3698,490 463.7%  
Other income Rs m1,202244 492.9%   
Total revenues Rs m40,5718,734 464.5%   
Gross profit Rs m181,482 1.2%  
Depreciation Rs m1,495211 708.0%   
Interest Rs m2,5550-   
Profit before tax Rs m-2,8301,514 -186.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,58266 -5,460.2%   
Tax Rs m257563 45.7%   
Profit after tax Rs m-6,6691,017 -655.4%  
Gross profit margin %017.5 0.3%  
Effective tax rate %-9.137.1 -24.5%   
Net profit margin %-16.912.0 -141.3%  
BALANCE SHEET DATA
Current assets Rs m33,79615,343 220.3%   
Current liabilities Rs m26,9171,960 1,373.2%   
Net working cap to sales %17.5157.6 11.1%  
Current ratio x1.37.8 16.0%  
Inventory Days Days7949 162.8%  
Debtors Days Days8928 313.7%  
Net fixed assets Rs m39,6641,209 3,279.9%   
Share capital Rs m553166 333.3%   
"Free" reserves Rs m27,96815,235 183.6%   
Net worth Rs m28,52215,401 185.2%   
Long term debt Rs m21,7310-   
Total assets Rs m81,62017,595 463.9%  
Interest coverage x-0.1NM-  
Debt to equity ratio x0.80-  
Sales to assets ratio x0.50.5 100.0%   
Return on assets %-5.05.8 -87.2%  
Return on equity %-23.46.6 -353.9%  
Return on capital %-7.710.3 -74.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,8071,636 599.3%   
Fx outflow Rs m1,7894,368 40.9%   
Net fx Rs m8,019-2,732 -293.5%   
CASH FLOW
From Operations Rs m684-1,304 -52.5%  
From Investments Rs m6,30212,697 49.6%  
From Financial Activity Rs m-7,695-301 2,560.6%  
Net Cashflow Rs m-66411,093 -6.0%  

Share Holding

Indian Promoters % 74.5 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 2.3 18.2 12.6%  
FIIs % 7.7 1.0 770.0%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 29.1 52.9%  
Shareholders   67,757 28,591 237.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  ELDER PHARMA  NOVARTIS  DR. DATSONS LABS  

Compare WOCKHARDT With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

How to Trade this Market Crash(Podcast)

India's #1 trader, Vijay Bhambwani, decodes the crash...and reveals hidden opportunities one could profit from.

Related Views on News

WOCKHARDT Announces Quarterly Results (3QFY20); Net Profit Up 125.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, WOCKHARDT has posted a net profit of Rs 192 m (up 125.0% YoY). Sales on the other hand came in at Rs 9 bn (down 16.9% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (2QFY20); Net Profit Down 13.0% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

More Views on News

Most Popular

Multibaggers of the Next Decade(The 5 Minute Wrapup)

Feb 26, 2020

The one key ingredient to be seen amongst top multibaggers of the next decade.

The Next Few Days Are Crucial for Smallcap Investors - And 3 Must-Buy Stocks(Profit Hunter)

Feb 19, 2020

While I have been writing about the rebound in smallcaps for quite some time now... I have shied from the question - When exactly is the smallcap rebound happening. Well, the answer is now.

The Top 8 Trading Mistakes You Should Avoid(Fast Profits Daily)

Feb 18, 2020

Avoid these mistakes and your trading will turn much more profitable.

Corona Virus Could Trigger a Rally in this Stock(Profit Hunter)

Feb 20, 2020

A company which benefits from crude oil and coronavirus - if you would like to know more about it read this.

This is What You Must Know as an Options Trader Today(Fast Profits Daily)

Feb 27, 2020

How you can stay on top of the challenges as an options trader.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Feb 28, 2020 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WOCKHARDT - TTK HEALTHCARE COMPARISON

COMPARE WOCKHARDT WITH

MARKET STATS